FIRST MANHATTAN CO. LLC. - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 117 filers reported holding THERAVANCE INC in Q4 2014. The put-call ratio across all filers is 3.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of THERAVANCE INC
ValueSharesWeighting
Q3 2015$21,000
-61.8%
2,940
-3.9%
0.00%
Q2 2015$55,000
-22.5%
3,060
-32.5%
0.00%
Q1 2015$71,000
-98.1%
4,530
-98.3%
0.00%
-100.0%
Q4 2014$3,800,000
-49.0%
268,580
-38.4%
0.02%
-48.8%
Q3 2014$7,449,000
-44.3%
435,880
-2.9%
0.04%
-49.4%
Q2 2014$13,367,000
-58.1%
448,887
-56.4%
0.08%
-59.5%
Q1 2014$31,867,000
+40.5%
1,029,977
+61.9%
0.21%
+40.0%
Q4 2013$22,674,000
+195.6%
636,030
+238.9%
0.15%
+177.8%
Q3 2013$7,671,000
+950.8%
187,700
+838.5%
0.05%
+980.0%
Q2 2013$730,00020,0000.01%
Other shareholders
THERAVANCE INC shareholders Q4 2014
NameSharesValueWeighting ↓
Baupost Group 20,395,056$607,365,0009.89%
Realm Partners LLC 301,521$8,979,0003.75%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,805,837$83,558,0002.52%
IRIDIAN ASSET MANAGEMENT LLC/CT 7,447,743$221,794,0002.27%
SECTORAL ASSET MANAGEMENT INC 1,743,188$51,912,0002.20%
Foundation Asset Management, LP 255,790$7,617,0002.19%
Proxima Capital Management, LLC 550,000$16,379,0001.93%
Roundview Capital LLC 140,645$4,188,0001.69%
BB BIOTECH AG 933,244$27,792,0001.32%
PERRY CAPITAL 1,517,208$45,182,0001.25%
View complete list of THERAVANCE INC shareholders